490
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Treatment options for multivessel coronary artery disease

, &
Pages 143-147 | Published online: 10 Jan 2014

References

  • Morrison DA, Sethi G, Sacks J et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J. Am. Coll. Cardiol. 38(1), 143–149 (2001).
  • Rodriguez A, Bernardi V, Navia J et al. Argentine Randomized Study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiplevessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J. Am. Coll. Cardiol. 37(1), 51–58 (2001).
  • Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 341(8845), 573–580 (1993).
  • CABRI trial participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet 346(8984), 1179–1184 (1995).
  • Bypass Angioplasty Revascularization Investigation (BARI) investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N. Engl. J. Med. 335(4), 217–225 (1996).
  • Rodriguez AE, Baldi J, Fernandez Pereira C et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J. Am. Coll. Cardiol. 46(4), 582–588 (2005).
  • SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 360(9338), 965–970 (2002).
  • Serruys PW, Unger F, van Hout BA et al. The ARTS study (Arterial Revascularization Therapies Study). Semin. Interv. Cardiol. 4(4), 209–219 (1999).
  • Serruys PW, Unger F, Sousa JE et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N. Engl. J. Med. 344(15), 1117–1124 (2001).
  • Serruys PW, Ong AT, van Herwerden LA et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J. Am. Coll. Cardiol. 46(4), 575–581 (2005).
  • Mercado N, Wijns W. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J. Thorac. Cardiovasc. Surg. 130(2), 512–529 (2005).
  • Arampatzis CA, Lemos PA, Hoye A et al. Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome. Catheter Cardiovasc. Interv. 62(3), 292–296; discussion 297 (2004).
  • Arampatzis CA, Lemos PA, Tanabe K et al. Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease. Am. J. Cardiol. 92(3), 327–329 (2003).
  • Chieffo A, Stankovic G, Bonizzoni E et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111(6), 791–795 (2005).
  • Lemos PA, Serruys PW, van Domburg RT et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the ‘real world’: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 109(2), 190–195 (2004).
  • Ong AT, Serruys PW, Aoki J, Hoye A et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J. Am. Coll. Cardiol. 45(7), 1135–1141 (2005).
  • Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108(14), 1701–1706 (2003).
  • Serruys P, Ong AT, Morice MC et al. Arterial Revascularisation Therapies Study Part II – sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention 2, 147–156 (2005)
  • Ong AT, Serruys PW, Mohr FW et al. The SYNergy between percutaneous coronary Intervention with TAXUS™ and cardiac surgery (SYNTAX) study: design, rationale and run-in phase. Am. Heart J. (2005) (In Press).
  • Sianos G, Morel MA, Kappetein AP et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2, 219–227 (2005).
  • Kapur A, Malik IS, Bagger JP et al. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. Am. Heart J. 149(1), 13–19 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.